Improved reaction conditions for the synthesis of new NKP-1339 derivatives and preliminary investigations on their anticancer potential

Axillary lymph node coverage of tangent radiotherapy: Comparison of supine versus prone positioning.

(2017) Gregory M. Thompson et al.   JOURNAL OF CLINICAL ONCOLOGY

NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application

(2014) Robert Trondl et al.   Chemical Science

The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo

(2013) Petra Heffeter et al.   EUROPEAN JOURNAL OF CANCER

Promising in Vitro anti-Alzheimer Properties for a Ruthenium(III) Complex

(2013) Luigi Messori et al.   ACS Medicinal Chemistry Letters

Cationic ruthenium(III) maltolato–imidazole complexes — Synthesis, characterization, and antiproliferatory activity*Adapted from the Ph.D. thesis of D.C. Kennedy (see the References section).

(2011) David C. Kennedy et al.   CANADIAN JOURNAL OF CHEMISTRY

ShelXle: a Qt graphical user interface forSHELXL

(2011) Christian B. Hübschle et al.   JOURNAL OF APPLIED CRYSTALLOGRAPHY

Influence of ascorbic acid on the activity of the investigational anticancer drug KP1019

(2011) Caroline Bartel et al.   JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY

Approaching tumour therapy beyond platinum drugs

(2011) A. Bergamo et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

An anti-cancer trinuclear ruthenium(iii) complex with 2-thiosalicylate ligands attenuates Wnt-β-catenin signaling

(2011) Sharon Lai-Fung Chan et al.   Chemical Science

Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339

(2010) Petra Heffeter et al.   JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY

Dual anti-angiogenic and cytotoxic properties of ruthenium(iii) complexes containing pyrazolato and/or pyrazole ligands

(2009) Raymond Wai-Yin Sun et al.   DALTON TRANSACTIONS

[OsIVCl5(Hazole)]−Complexes: Synthesis, Structure, Spectroscopic Properties, and Antiproliferative Activity

(2009) Gabriel E. Büchel et al.   INORGANIC CHEMISTRY

OLEX2: a complete structure solution, refinement and analysis program

(2009) Oleg V. Dolomanov et al.   JOURNAL OF APPLIED CRYSTALLOGRAPHY

Recent developments in ruthenium anticancer drugs

(2009) Aviva Levina et al.   Metallomics

Synthesis and Reactivity of the Aquation Product of the Antitumor Complextrans-[RuIIICl4(indazole)2]−

(2008) Berta Cebrián-Losantos et al.   INORGANIC CHEMISTRY

Development of an experimental protocol for uptake studies of metal compounds in adherent tumor cells

(2008) Alexander E. Egger et al.   JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY

Electron-transfer activated metal-based anticancer drugs

(2006) Erwin Reisner et al.   INORGANICA CHIMICA ACTA